Rasoul Aliannejad

Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series

Seyed Mohammad Reza Hashemian, Rasoul Aliannejad, Morteza Zarrabi et al. · Stem Cell Research & Therapy · 2021 · 197 citations · Full text

Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial

Anahita Sadeghı, Ali Asgari, Alireza Norouzi et al. · Journal of Antimicrobial Chemotherapy · 2020 · 129 citations · Full text

Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial

Morteza Zarrabi, Mohammad Amin Shahrbaf, Masoumeh Nouri et al. · Stem Cell Research & Therapy · 2023 · 84 citations · Full text

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial

Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi et al. · Thrombosis and Haemostasis · 2021 · 78 citations · Full text

Cell therapy in patients with COVID-19 using Wharton’s jelly mesenchymal stem cells: a phase 1 clinical trial

Mahshid Saleh, Amir Abbas Vaezi, Rasoul Aliannejad et al. · Stem Cell Research & Therapy · 2021 · 76 citations · Full text